StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note published on Tuesday morning. The brokerage issued a hold rating on the stock.
Milestone Scientific Price Performance
Shares of NYSE MLSS opened at $0.55 on Tuesday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.35. The business’s fifty day moving average price is $0.66 and its 200-day moving average price is $0.71. The stock has a market capitalization of $42.21 million, a PE ratio of -5.51 and a beta of 0.97.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. The business had revenue of $2.26 million during the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%.
Institutional Inflows and Outflows
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.
Further Reading
- Five stocks we like better than Milestone Scientific
- 3 Monster Growth Stocks to Buy Now
- Comprehensive Analysis of PayPal Stock
- Why Invest in High-Yield Dividend Stocks?
- Intuitive Surgical Stock Can Trend Much Higher This Year
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.